Valganciclovir is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of CMV retinitis (AIDS).
- Prevention of CMV disease: renal, cardiac and kidney-pancreas transplant patients at high risk for CMV disease (e.g., donor positive, recipient negative).
- Not indicated in liver transplant patients.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Prevention of disseminated CMV disease of the contralateral eye in patients treated with intraocular ganciclovir implant (no longer manufactured).
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: January 6, 2016
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Valganciclovir
ID - 540577
A1 - Pham,Paul,Pharm.D.
AU - Dzintars,Kathryn,Pharm.D., BCPS
AU - Hsu,Alice,Pharm.D.
Y1 - 2016/01/06/
PB - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540577/all/Valganciclovir
ER -